Abstract Number: 38

Vitiligo – an approach to treatment

M. Rodrigues

Meeting: 2015 Dermcoll

Session Information

Date: -

Session Title: Pigmentary Diseases Symposium

Session Time: -

Vitiligo is an acquired chronic pigmentary disorder affecting
0.5–2% of the world’s population, with equal incidence in
men and women. This depigmenting condition is thought
to be autoimmune though the exact aeitopathogenesis
remains unclear.
This cosmetically challenging and often psychologically
devastating condition necessitates a thorough understanding of topical, physical and surgical treatments available for
affected patients. An approach to the treatment of vitiligo
and different treatment modalities will be discussed as well
as the latest discoveries and potential future therapies.